Portrait of a woman with auburn hair in an alpine meadow, illustrating biological age and longevity
Longevity··6 min briefing

Your Body Has Two Ages. Can You Really Measure the Second One?

You have two ages, and only one is on your licence. The second one is real, but the test that claims to read it disagrees with itself by years, and every famous study that 'reversed' it was paid for by someone selling something. Here is the honest scoreboard.

Updated July 2026 · Reviewed by Roy Sañudo S.

Your Body Has Two Ages. Can You Really Measure the Second One?

0:00 / 6 min briefing

Speed:
Read transcript

Key Takeaways

  • Biological age is a real idea: across a population, DNA clocks predict health better than a birth date does
  • But split one blood sample in two and the same clock disagrees with itself by 1.8 to 2.4 years on average, and by up to 8.6
  • Every famous 'reversal' trial was funded by someone with a stake in the result
  • The best study, CALERIE, slowed one clock by 2 to 3% and left two other clocks flat
  • On 9 June 2026 the first human was dosed with cell reprogramming. It is a glaucoma safety trial, not an anti-aging pill.

Two people are sixty. One takes the stairs without thinking about it. The other plans the day around their back. Same birthday, a decade apart in everything that matters. You already know which one you are drifting toward, because you have watched it happen to people you know. The open question is whether anyone can hand you the number.

What is biological age?

Your real age counts birthdays. Your biological age is an estimate of how worn your cells are, and the two can disagree by years in either direction.

Think of it this way. Your birthday is the year stamped on the chassis. Your biological age is the mileage. A well-maintained 2010 model outruns a neglected 2020 every time.

So how does a lab read the mileage? It looks at tiny chemical tags on your DNA, called methylation marks, that switch on and off in a fairly predictable pattern as the years pass. Add them up and you get an estimate. Scientists call it an epigenetic clock. Steve Horvath built the first widely used one at UCLA in 2013, and versions of it sit behind every study below.

At the scale of a whole population, it works. Across thousands of people, these clocks predict disease and death better than a birth date does. That much is well established, including by the researchers who are hardest on the test. The argument is about you.

Can you actually lower your biological age?

Possibly, a little. But before you trust any headline about it, notice the pattern underneath all three of the famous studies: the study that proves the product was usually paid for by the people selling it. In this field that is not a scandal. It is the default. Here they are.

The strongest one is a real trial. CALERIE randomly assigned 220 healthy adults to eat less for two years. The target was 25% fewer calories; people actually managed 11.9%. One clock showed them aging about 2 to 3% slower. Two other clocks showed nothing at all, in the same people, from the same blood. And the line you have read everywhere, that this means a 10 to 15% lower chance of dying early, is not a result of this trial at all. It is the authors' own careful guess, borrowed from separate research. CALERIE measured no deaths.

The "three years younger in eight weeks" study was real and randomized: 18 men treated, 20 as controls. It was paid for by Metagenics, whose supplements were the treatment, and corrected in March 2024, rewriting its abstract, its results and two of its figures.

The trial that started the whole "reversal" story, TRIIM, was nine men with no control group, funded by a company its lead author co-founded and holds shares in. Six months on, the effect was drifting back.

The same shape sits inside the NMN trial everyone quotes.

Why can't a test just tell you your number?

Because the clock disagrees with itself.

In 2022, researchers ran the obvious experiment almost nobody had bothered with. They took one blood sample, split it in two, and put both halves through the same clock. The two halves came back a median of 1.8 to 2.4 years apart. In the worst cases, 8.6 years apart. Same blood. Same day. Same machine.

So if a test tells you that you are three years younger than your birthday, and the test cannot tell three years from nothing, the three years are not information. They are static.

One person put that to the test in public. A writer sent his own sample to seven companies over two days and paid $3,143.99 for the answers. They came back ranging from 24.9 to 38. That is one man's shopping trip, not a study. But it is a thirteen-year spread from one body in one week, and it is exactly what the split-sample data predicts.

The person saying this loudest is not a critic. It is Steve Horvath, who built the clock. His own score moved four years in six months. "You cannot directly relate it to how long you'll live," he told MIT Technology Review in 2022. Morgan Levine, who built one of the other clocks, told the same magazine that an individual reading can be off by decades. In 2026, Horvath told a precision-medicine conference that you still cannot send one sample to two properly validated labs and get the same answer back.

That 2022 paper also published a statistical fix, and it works. The corrected clocks are not the ones being sold to you.

Should you buy an at-home biological age test?

Not to answer the question you actually want answered.

If you are buying it to learn how old you really are, it cannot tell you. That is not an accusation against any one company; it is just what the numbers above mean.

There is one honest use: read the slope, never the number. One lab, at least three tests, six months apart, same conditions each time, and ignore any single reading. That is a real discipline. Almost nobody keeps it, which is why the test usually sells a feeling rather than a fact.

The price moved the wrong way, too. The full panel this article once pointed readers to has gone from $229 to $499. The $229 tier still exists, but it now buys a smaller, different test. Nothing about the instrument improved. What improved was the story around it.

If you want numbers that move and mean something, the boring ones are better. How out of breath you get on a hill. How hard you can squeeze. Your blood pressure. Your HbA1c, which is your average blood sugar over about three months. Your hs-CRP, a cheap blood test for hidden inflammation. They cost less, they repeat cheaply, and they have decades of outcomes standing behind them.

What changed in June 2026?

Something real, and it is not in a bottle.

In 2020, David Sinclair's lab at Harvard published a result in Nature that read like science fiction. They used a harmless virus to carry three genes into the eye cells of mice, asking those cells to reload an older, cleaner copy of their own instructions. Mice whose optic nerves had been crushed could see again. Naturally aged mice got sharper sight back.

For six years the honest caption on that was: mice only, humans someday.

Someday arrived on 9 June 2026. Life Biosciences, which Sinclair co-founded, dosed the first human being ever with this kind of cell reprogramming. It is a Phase 1 safety trial, in people with glaucoma, asking whether it is safe inside an eye. It is not an anti-aging treatment, and nobody can buy it.

Notice what that trial measures, though. Not a clock reading. Whether a person can see. That is the bar this whole field has to clear, and it is the reason the number in your inbox does not matter yet.

What actually works while we wait?

The things that move your biology are the ones you already suspect. Each comes with an honest asterisk.

Sleep is when your body does most of its repair. Seven hours or more, and morning light to set the clock that runs it.

Get out of breath. Cardiorespiratory fitness, which is how well your heart and lungs handle hard work, is one of the strongest predictors of how long people live, and unlike a methylation score, you can feel it change.

Eat less; a window is one way to do it. Salk's early trial found benefits from a 10-hour eating window, and it is an easy rule to hold. Be fair about it though: two larger trials since, TREAT and one in the New England Journal, found the window added nothing beyond simply eating less. So it is a tool, not a trick. We go through that whole argument here.

Heat. University of Eastern Finland researchers followed 2,315 men for about twenty years. Those who used a sauna 4 to 7 times a week had lower rates of dementia and heart disease. It watched people rather than testing them, so it cannot prove cause.

Cold. Winter swimmers studied at the University of Copenhagen had more active brown fat and better blood sugar control. Also a snapshot, not a trial. Here is what cold actually does.

You have two ages. The first is on your licence and it is honest. The second is real, and for now nobody can hand you its number without a margin of error wide enough to drive through. That is not bad news. It just means the answer was never going to arrive in the post. It arrives in how you sleep tonight. Here is how I live with that.

Where the science stands

Our read after cross-checking every study and expert view.

Key findings

  • Strong evidenceMeasured twice from the same blood draw, the standard epigenetic clocks disagree with themselves by a median of 1.8 to 2.4 years, and by as much as 8.6 (Higgins-Chen et al., Nature Aging, 2022). The margin of error is wider than most results people are told to act on.
  • Strong evidenceNo epigenetic clock has been validated as a surrogate endpoint. The FDA lists none. Nobody has shown that lowering a clock reading changes a health outcome. We are treating the thermometer as if it were the fever.
  • Moderate evidenceIn CALERIE, the only RCT-grade evidence in the field, participants achieved 11.9% calorie restriction against a 25% target. DunedinPACE slowed about 2 to 3%; PhenoAge and GrimAge showed no effect in the same people. The 10 to 15% mortality figure widely attributed to this trial is the authors' own hedged extrapolation. CALERIE measured no deaths.
  • Early signalOn 9 June 2026, Life Biosciences dosed the first human ever with OSK partial reprogramming, the approach from Sinclair's 2020 mouse work. It is a Phase 1 safety trial in glaucoma, not an aging treatment.

Where the research agrees

That biological age is real and worth understanding. Across thousands of people, DNA methylation clocks predict disease and death better than a birth date does, and no one disputes it. Everyone also agrees, including the researchers who built the clocks, that a single reading cannot yet tell one person their number. Steve Horvath's own score moved four years in six months, and he says you cannot yet get the same readout from two validated labs.

Where it's still debated

Whether the test is worth buying at all. Researchers argue an individual result is indistinguishable from measurement noise, and that group averages from a trial never license a personal claim. Experienced users argue the number is usable as a trend, given one lab, three or more tests, six months apart and fixed conditions, a discipline almost nobody applies. Nobody has yet run the study that would settle it: does a change in your clock reading predict your health better than a cheap fitness test does? Separately, the theory underneath the headlines is itself contested: Timmons and Brenner argued in Cell in 2024 that the tool used to build Sinclair's 'ICE' mice is independently damaging to DNA, which would mean the experiment showed something other than lost epigenetic information. Sinclair's lab published a rebuttal in the same issue. It is unresolved.

Scientific References

This article synthesizes research from the following institutions and studies. All content is derived from peer-reviewed scientific literature and leading research centers.

Harvard Glenn Center for the Biological Mechanisms of Aging (Dr. David Sinclair). Disclosed affiliations include Life Biosciences, Animal Bioscience, InsideTracker and MetroBiotech.

Horvath S., Genome Biology: "DNA methylation age of human tissues and cell types" (2013). 14:R115. UCLA — the first widely used pan-tissue epigenetic clock.

Higgins-Chen A.T., Thrush K.L., Levine M.E. et al., Nature Aging: "A computational solution for bolstering reliability of epigenetic clocks" (2022). Technical replicates of a single blood draw deviated by a median of 1.8-2.4 years (max 8.6) on the original Horvath/PhenoAge clocks; principal-component correction raises reliability to ICC >0.97.

Waziry R., Ryan C.P., ... Belsky D.W., Nature Aging: "Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial" (2023). PMID 37118425. DOI 10.1038/s43587-022-00357-y. RCT, n=220. Achieved restriction 11.9% against a 25% target; DunedinPACE slowed ~2-3%; PhenoAge and GrimAge showed no effect. Post-hoc analysis; no mortality outcome measured.

Fahy G.M. et al., Aging Cell: "Reversal of epigenetic aging and immunosenescent trends in humans" (TRIIM, 2019). PMID 31496122. DOI 10.1111/acel.13028. n=9, single-arm, no control group. Sponsored by Intervene Immune, Inc.; the lead author is an officer and shareholder.

Fitzgerald K.N., Hodges R., Hanes D. et al., Aging: "Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial" (2021). PMID 33844651. DOI 10.18632/aging.202913. 18 treated / 20 control. Funded by an unrestricted grant from Metagenics, Inc., whose products constituted the intervention. Substantively corrected March 2024 (PMID 38488762).

Lu Y. et al., Nature: "Reprogramming to recover youthful epigenetic information and restore vision" (2020). PMID 33268865. DOI 10.1038/s41586-020-2975-4. OSK (Myc omitted); mouse.

Life Biosciences ER-100, ClinicalTrials.gov NCT07290244. FDA IND cleared 28 Jan 2026; first human dosed 9 Jun 2026. Phase 1, open-angle glaucoma and NAION — the first human dosing of partial epigenetic reprogramming.

Yang J.H. et al., Cell: "Loss of epigenetic information as a cause of mammalian aging" (2023) — contested. Timmons J.A. & Brenner C. argue in a 2024 Matters Arising (Cell) that the endonuclease used to build the ICE mice is independently genotoxic; the Sinclair lab published a rebuttal in the same issue. Unresolved.

Curated by Roy Sañudo S.

Research Curator, Anima Cosmi

Anima Cosmi translates peer-reviewed research from Harvard, Oxford, Stanford, the Salk Institute, and other leading labs into plain language. Every article names its researchers, institutions, and publication years, so you can check the sources yourself.

Not medical advice. Anima Cosmi is a research curator, not a medical practice: this is education, not a prescription. Talk to a qualified healthcare provider before starting any new supplement, diet, or routine, especially if you take medication or have a health condition.


Continue Reading